Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04759248
Title Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer (ATREZZO)
Acronym ATREZZO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
H. Clínico San Cecilio de Granada RECRUITING Granada Andalucía Spain Details
Institut Català d'Oncologia Hospitalet RECRUITING Hospitalet de Llobregat Barcelona Spain Details
Hospital Universitario de Canarias RECRUITING Tenerife Islas Canarias 38320 Spain Details
Complejo Hospitalario Universitario A Coruña (CHUAC) RECRUITING A Coruña La Coruña 15006 Spain Details
Hospital General Universitario de Alicante RECRUITING Alicante Spain Details
Hospital del Mar RECRUITING Barcelona 08003 Spain Details
Hospital Clinic de Barcelona RECRUITING Barcelona Spain Details
Hospital Universitari Vall d' Hebron RECRUITING Barcelona Spain Details
Hospital San Pedro de Alcántara RECRUITING Cáceres Spain Details
Hospital de León RECRUITING León 24071 Spain Details
Hospital Universitario 12 de octubre RECRUITING Madrid Spain Details
Hospital Son Espases RECRUITING Palma De Mallorca Spain Details
Hospital Universitari Sant Joan de Reus RECRUITING Reus 43201 Spain Details
Hospital Universitario Virgen del Rocio RECRUITING Sevilla Spain Details
Hospital Clinico Universitario de Valencia RECRUITING Valencia Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field